These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15285632)

  • 1. [Use of cholinomimetics in the treatment of endogenous autism in children].
    Krasnoperova MG; Simashkova NV; Bashina VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(6):35-9. PubMed ID: 15285632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An effect of long-term cerebrolysin therapy in combination with neuroleptics on behavioral and cognitive disturbances in endogenous childhood autism].
    Radzivil MG; Bashina VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(2):21-5. PubMed ID: 16548370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical observation of aripiprazole in the treatment of autism].
    Xie Q; Tang J; Xu Y; Zeng HL
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Apr; 15(4):294-7. PubMed ID: 23607954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.
    Research Units on Pediatric Psychopharmacology Autism Network
    Am J Psychiatry; 2005 Jul; 162(7):1361-9. PubMed ID: 15994720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open trial of risperidone in 24 young children with pervasive developmental disorders.
    Masi G; Cosenza A; Mucci M; Brovedani P
    J Am Acad Child Adolesc Psychiatry; 2001 Oct; 40(10):1206-14. PubMed ID: 11589534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of cerepro (choline alfoscerate) in the treatment of outpatients with chronic progressive cerebrovascular disease].
    Kostenko EV; Petrova LV; Artemova IIu; Vdovichenko TV; Ganzhula PA; Ismailov AM; Lisenker LN; Petrov SV; Otcheskaia OV; Rotor LD; Khozova AA; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 1):24-30. PubMed ID: 22677751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.
    Rezaei V; Mohammadi MR; Ghanizadeh A; Sahraian A; Tabrizi M; Rezazadeh SA; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1269-72. PubMed ID: 20637249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ziprasidone in adolescents with autism: an open-label pilot study.
    Malone RP; Delaney MA; Hyman SB; Cater JR
    J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):779-90. PubMed ID: 18315450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open clinical trial of risperidone monotherapy in young children with autistic disorder.
    Findling RL; Maxwell K; Wiznitzer M
    Psychopharmacol Bull; 1997; 33(1):155-9. PubMed ID: 9133768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disturbances in dopamine metabolism in autistic children: results of clinical tests and urinary dosages of homovanilic acid (HVA)].
    Garreau B; Barthelemy C; Domenech J; Sauvage D; Muh JP; Lelord G; Callaway E
    Acta Psychiatr Belg; 1980; 80(3):249-65. PubMed ID: 6111177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
    Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pilot Study on the Combination of Applied Behavior Analysis and Bumetanide Treatment for Children with Autism.
    Du L; Shan L; Wang B; Li H; Xu Z; Staal WG; Jia F
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):585-8. PubMed ID: 26258842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open trial of risperidone in young autistic children.
    Nicolson R; Awad G; Sloman L
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):372-6. PubMed ID: 9549957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.
    Valicenti-McDermott MR; Demb H
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):549-60. PubMed ID: 17069544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.
    Akhondzadeh S; Fallah J; Mohammadi MR; Imani R; Mohammadi M; Salehi B; Ghanizadeh A; Raznahan M; Mohebbi-Rasa S; Rezazadeh SA; Forghani S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):32-6. PubMed ID: 19772883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety.
    Nikoo M; Radnia H; Farokhnia M; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2015; 38(1):11-7. PubMed ID: 25580916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions.
    Correia CT; Almeida JP; Santos PE; Sequeira AF; Marques CE; Miguel TS; Abreu RL; Oliveira GG; Vicente AM
    Pharmacogenomics J; 2010 Oct; 10(5):418-30. PubMed ID: 19997080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of behavioral disorders by risperidone in children with autism].
    Wei BY; Huang F; Qin XT; Liang QQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Mar; 13(3):216-8. PubMed ID: 21426640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.